[HTML][HTML] Oncolytic Viral Therapy in Osteosarcoma

T Karadimas, TH Huynh, C Chose, G Zervoudakis… - Viruses, 2024 - mdpi.com
Primary bone malignancies, including osteosarcoma (OS), are rare but aggressive. Current
OS treatment, involving surgical resection and chemotherapy, has improved survival for non …

Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c‐Myc‐mediated BCAT1 …

Z Li, D Meng, Y Liu, F Bi, K Tian, J Xu… - … of Biochemical and …, 2024 - Wiley Online Library
Increasing evidence indicated that protein arginine methyltransferase‐1 (PRMT1) is an
oncogene in multiple malignant tumors, including osteosarcoma (OS). The aim of this study …

A novel Ni-based complex inducing apoptosis through mitochondrial dysfunction in osteosarcoma HOS cells

XD Liu, PX Liu, Z Zhang, LL Li, J Luan… - New Journal of Chemistry, 2024 - pubs.rsc.org
Osteosarcoma, a common primary cancer of the bone in young people, presents major
difficulties in medical care because of its resistance to chemotherapy and poor outlook …

Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets

Y Liu, B Jiang, Y Li, X Zhang, L Wang, Y Yao, B Zhu… - Medicine, 2024 - journals.lww.com
Osteosarcoma (OS) has a high recurrence rate, disability rate, mortality and metastasis, it
brings great economic burden and psychological pressure to patients, and then seriously …

Diagnostic value of combined detection of AKP, TSGF, and LDH for pediatric osteosarcoma: a case-control study

T Sun, J Ma, S Zhu, K Wang - American Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Objective: To evaluate the diagnostic value of serum alkaline phosphatase (AKP), tumor-
supplied growth factor group (TSGF), and lactate dehydrogenase (LDH) for pediatric …

Successful treatment of osteosarcoma in a pregnant woman with survival of the gestational product: A case report and literature review

CA Orpinel-González… - Medicine …, 2024 - spandidos-publications.com
Osteosarcoma (OS) is the most prevalent bone neoplasm of mesenchymal origin,
accounting for 20% of all bone tumors worldwide. It mainly affects the marrow of long bones …

Computational approach in searching for dual action multitarget inhibitors for osteosarcoma

MA Gani, AD Nurhan, BRKH Putri… - Journal of Advanced …, 2023 - journals.lww.com
Osteosarcoma is a common primary malignant bone tumor that typically manifests in the
second decade of life. This study aimed to identify osteogenic compounds that potentially …